| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia
|
Howard, Dianna S.
|
|
2013
|
37 |
11 |
p. 1502-1508
7 p.
|
artikel
|
| 2 |
CEBPA single mutation can be a possible favorable prognostic indicator in NPM1 and FLT3-ITD wild-type acute myeloid leukemia patients with intermediate cytogenetic risk
|
Park, Sang Hyuk
|
|
2013
|
37 |
11 |
p. 1488-1494
7 p.
|
artikel
|
| 3 |
Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy
|
Lou, Yinjun
|
|
2013
|
37 |
11 |
p. 1451-1456
6 p.
|
artikel
|
| 4 |
Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1
|
Pullarkat, Sheeja T.
|
|
2013
|
37 |
11 |
p. 1572-1575
4 p.
|
artikel
|
| 5 |
CUEDC2 sensitizes chronic myeloid leukemic cells to imatinib treatment
|
Zhang, Hongju
|
|
2013
|
37 |
11 |
p. 1583-1591
9 p.
|
artikel
|
| 6 |
Cytogenetic response based on revised IPSS cytogenetic risk stratification and minimal residual disease monitoring by FISH in MDS patients treated with low-dose decitabine
|
Li, Xiao
|
|
2013
|
37 |
11 |
p. 1516-1521
6 p.
|
artikel
|
| 7 |
Distinct sensitivity of CD8+CD4− and CD8+CD4+ leukemic cell subpopulations to cyclophosphamide and rapamycin in Notch1-induced T-ALL mouse model
|
Zhang, Yingchi
|
|
2013
|
37 |
11 |
p. 1592-1601
10 p.
|
artikel
|
| 8 |
DNMT3A mutation is a poor prognosis biomarker in AML: Results of a meta-analysis of 4500 AML patients
|
Shivarov, Velizar
|
|
2013
|
37 |
11 |
p. 1445-1450
6 p.
|
artikel
|
| 9 |
DNMT3A mutations in AML: A new prognostic factor?
|
Schwarz, Jiří
|
|
2013
|
37 |
11 |
p. 1432-1433
2 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2013
|
37 |
11 |
p. CO2-
1 p.
|
artikel
|
| 11 |
EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemia
|
Tiribelli, Mario
|
|
2013
|
37 |
11 |
p. 1457-1460
4 p.
|
artikel
|
| 12 |
Genetic variants in DNA repair pathways are not associated with disease progression among multiple myeloma patients
|
Thyagarajan, Bharat
|
|
2013
|
37 |
11 |
p. 1527-1531
5 p.
|
artikel
|
| 13 |
Hematogones: An overview
|
Chantepie, S.P.
|
|
2013
|
37 |
11 |
p. 1404-1411
8 p.
|
artikel
|
| 14 |
Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells
|
Tanios, Rita
|
|
2013
|
37 |
11 |
p. 1565-1571
7 p.
|
artikel
|
| 15 |
Income and outcome in myelodysplastic syndrome: The prognostic impact of SES in a single-payer system
|
England, James T.
|
|
2013
|
37 |
11 |
p. 1495-1501
7 p.
|
artikel
|
| 16 |
Increased expression of phosphorylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromes
|
Kefala, Maria
|
|
2013
|
37 |
11 |
p. 1576-1582
7 p.
|
artikel
|
| 17 |
Increased prevalence of autoimmune phenomena in myelofibrosis: Relationship with clinical and morphological characteristics, and with immunoregulatory cytokine patterns
|
Barcellini, Wilma
|
|
2013
|
37 |
11 |
p. 1509-1515
7 p.
|
artikel
|
| 18 |
“It's effective therapy, stupid!”
|
Ravandi, Farhad
|
|
2013
|
37 |
11 |
p. 1434-1435
2 p.
|
artikel
|
| 19 |
Methylation of the DPH1 promoter causes immunotoxin resistance in acute lymphoblastic leukemia cell line KOPN-8
|
Hu, Xiaobo
|
|
2013
|
37 |
11 |
p. 1551-1556
6 p.
|
artikel
|
| 20 |
Modest activity of pomalidomide in patients with myelofibrosis and significant anemia
|
Daver, Naval
|
|
2013
|
37 |
11 |
p. 1440-1444
5 p.
|
artikel
|
| 21 |
Patients with polycythemia vera and essential thrombocythemia with prior malignancy do not have significantly worse outcome
|
Cherry, Mohamad
|
|
2013
|
37 |
11 |
p. 1472-1476
5 p.
|
artikel
|
| 22 |
Phase I clinical, pharmacokinetic, and pharmacodynamic study of the Akt-inhibitor triciribine phosphate monohydrate in patients with advanced hematologic malignancies
|
Sampath, Deepa
|
|
2013
|
37 |
11 |
p. 1461-1467
7 p.
|
artikel
|
| 23 |
Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age
|
Vigil, Carlos E.
|
|
2013
|
37 |
11 |
p. 1468-1471
4 p.
|
artikel
|
| 24 |
Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia
|
Shimizu, Hiroaki
|
|
2013
|
37 |
11 |
p. 1477-1481
5 p.
|
artikel
|
| 25 |
Pyothorax-associated lymphoma (PAL) with biclonal Epstein–Barr virus infection: Characterization of a novel PAL cell line with unique features
|
Taniguchi, Ayuko
|
|
2013
|
37 |
11 |
p. 1545-1550
6 p.
|
artikel
|
| 26 |
Recovery of natural killer cells and prognosis after cord blood transplantation
|
Yamamoto, Wataru
|
|
2013
|
37 |
11 |
p. 1522-1526
5 p.
|
artikel
|
| 27 |
Reduced-intensity conditioning therapy with fludarabine, idarubicin, busulfan and cytarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndrome
|
Gao, Li
|
|
2013
|
37 |
11 |
p. 1482-1487
6 p.
|
artikel
|
| 28 |
Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL)
|
Mazan-Mamczarz, Krystyna
|
|
2013
|
37 |
11 |
p. 1420-1428
9 p.
|
artikel
|
| 29 |
Striving to achieve safe, permanent treatment discontinuation in chronic myeloid leukemia
|
Mauro, Michael J.
|
|
2013
|
37 |
11 |
p. 1395-1403
9 p.
|
artikel
|
| 30 |
Struggling with myelofibrosis-associated anemia
|
Guglielmelli, Paola
|
|
2013
|
37 |
11 |
p. 1429-1431
3 p.
|
artikel
|
| 31 |
Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome
|
Poloni, Antonella
|
|
2013
|
37 |
11 |
p. 1538-1544
7 p.
|
artikel
|
| 32 |
The E3 ubiquitin ligase TRAF2 can contribute to TNF-α resistance in FLT3-ITD-positive AML cells
|
Schnetzke, Ulf
|
|
2013
|
37 |
11 |
p. 1557-1564
8 p.
|
artikel
|
| 33 |
The pros and cons of new prognostic eutos score for chronic myeloid leukemia patients
|
Breccia, Massimo
|
|
2013
|
37 |
11 |
p. 1436-1437
2 p.
|
artikel
|
| 34 |
The role of SOX11 in mantle cell lymphoma
|
Lu, Ting-Xun
|
|
2013
|
37 |
11 |
p. 1412-1419
8 p.
|
artikel
|
| 35 |
Unravelling survival pathways: The road to next-generation chronic myeloid leukaemia drugs?
|
Deeren, Dries
|
|
2013
|
37 |
11 |
p. 1438-1439
2 p.
|
artikel
|
| 36 |
Wnt5a enhances the response of CML cells to Imatinib Mesylate through JNK activation and γ-catenin inhibition
|
Niu, Chang-Chun
|
|
2013
|
37 |
11 |
p. 1532-1537
6 p.
|
artikel
|
Tijdschrift beschrijving